inhatarget.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /gdpr Disallow: /team/ Sitemap: | ||
Meta Tags
| Title | Innovative inhalation formulations for severe respiratory |
| Description | Innovative treatments by Inhatarget Therapeutics develops targeted inhalation formulations to improve treatment for severe respiratory diseases, with a first focus on lung |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 87.98.154.146 |
| Location | France |
Related Websites
| Site | Rank |
More to Explore
inhatarget.com Valuation
|
US$570,787
Last updated: 2023-05-17 02:16:03
inhatarget.com has Semrush global rank of 18,543,365. inhatarget.com has an estimated worth of US$ 570,787, based on its estimated Ads revenue. inhatarget.com receives approximately 65,860 unique visitors each day. Its web server is located in France, with IP address 87.98.154.146. According to SiteAdvisor, inhatarget.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$570,787 |
| Daily Ads Revenue | US$527 |
| Monthly Ads Revenue | US$15,807 |
| Yearly Ads Revenue | US$189,677 |
| Daily Unique Visitors | 4,391 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| inhatarget.com. | A | 3595 | IP: 87.98.154.146 |
| inhatarget.com. | NS | 3600 | NS Record: ns112.ovh.net. |
| inhatarget.com. | NS | 3600 | NS Record: dns112.ovh.net. |
| inhatarget.com. | MX | 3600 | MX Record: 0 inhatarget-com.mail.protection.outlook.com. |
| inhatarget.com. | TXT | 3600 | TXT Record: MS=ms59366242 |
| inhatarget.com. | TXT | 3600 | TXT Record: 3|welcome |
| inhatarget.com. | TXT | 3600 | TXT Record: 1|www.inhatarget.com |
| inhatarget.com. | TXT | 3600 | TXT Record: l|fr |
| inhatarget.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-17 02:16:03
| About Us Company History Our Mission Our Team Technology Pipeline Clinical Trial News Contact Us Contact Us Innovative treatments by inhalation InhaTarget Therapeutics develops innovative and targeted formulations for inhalation to improve the treatment of severe respiratory diseases. InhaTarget Therapeutics is a spin-off company from the University of Brussels (ULB) - Belgium, dedicated to the early development and clinical validation of innovative treatments of pulmonary diseases by inhalation, with a first focus on lung cancer. The company was established in August 2019 and brings together strong complementary expertise in drug formulation, inhalation delivery, immunology, preclinical development and clinical operations. About Us Technology Clinical Trial Our mission Change the game of existing molecules through novel and improved treatment modalities in terms of route of administration, frequency of treatment, mechanism of action, or compound stability. Learn More Our latest news |
inhatarget.com Whois Information
Domain Name: INHATARGET.COM Registry Domain ID: 2290516421_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.ovh.com Registrar URL: http://www.ovh.com Updated Date: 2021-12-10T09:55:16Z Creation Date: 2018-07-27T09:33:14Z Registry Expiry Date: 2022-07-27T09:33:14Z Registrar: OVH sas Registrar IANA ID: 433 Registrar Abuse Contact Email: abuse@ovh.net Registrar Abuse Contact Phone: +33.972101007 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS112.OVH.NET Name Server: NS112.OVH.NET DNSSEC: unsigned >>> Last update of whois database: 2022-02-27T10:52:49Z <<< |